Genelux

GNLX · NASDAQ

$2.50+$0.05 (+2.04%)TodayMarket closed ·
Prev close $2.45

Latest news

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releaseGlobe Newswire

    Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates

  • Press releaseGlobe Newswire

    Attovia Therapeutics Appoints John W. Smither to Board of Directors

  • Press releaseGlobe Newswire

    Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates

  • Press releaseGlobe Newswire

    Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

  • Press releaseGlobe Newswire

    Genelux Corporation to Participate in Upcoming Conferences

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releaseGlobe Newswire

    Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials

  • Press releaseGlobe Newswire

    Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • Press releaseGlobe Newswire

    Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • Press releaseGlobe Newswire

    Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • Press releaseGlobe Newswire

    Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • Press releaseGlobe Newswire

    Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates

  • Press releaseGlobe Newswire

    Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

  • Press releaseBusiness Wire

    Frazier Life Sciences Appoints John Smither and Jim Williams as Senior Advisors

  • NewsAvi Kapoor

    Disney To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday

  • NewsAvi Kapoor

    Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.